
Irnotop 40mg Injection
Marketer
Metta Life Sciences Private Limited
Salt Composition
Irinotecan (40mg)
Overview Irnotop 40mg Injection
Oncotop 40mg Injection is indicated for colorectal cancer management. Its mechanism involves inhibiting or reducing the proliferation of cancerous cells. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your individual needs and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for several weeks or months; discontinue only under medical supervision. Common side effects include tiredness, nausea, vomiting, debility, and alopecia. This medication can lower blood cell counts (red and white), increasing infection risk. Report fever, sore throat, or persistent diarrhea to your doctor. Regular blood work monitoring blood cell levels, cardiac function, liver health, and uric acid is necessary. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, or the use of antimicrobial agents. Inform your medical team of all medications you are currently taking, as interactions are possible. This medication is contraindicated during pregnancy and lactation. Reliable contraception for both partners is crucial throughout treatment to prevent conception.
Primary Ingredients of Irnotop 40mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Irnotop 40mg Injection
Colorectal cancer
Major Benefits of Irnotop 40mg Injection:
The medication will be administered by your physician or their registered nurse; self-medication is strictly prohibited.
Common Side effects of Irnotop 40mg Injection:
- Fatigue
- Nausea
- Vomiting
- Weakness
- Hair loss
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Decreased appetite
- Mucosal inflammation
How to use Irnotop 40mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Irnotop 40mg Injection works:
Injex Irnotop 40mg is a cancer treatment that inhibits topoisomerase I, a crucial enzyme for DNA replication in cancerous cells. This inhibition reduces the proliferation of cancer cells, leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Irnotop 40mg Injection with alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Irnotop 40mg Injection during pregnancy is contraindicated due to established risks to the fetus. In exceptional circumstances involving life-threatening conditions, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Irnotop 40mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Irnotop 40mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving is prohibited if such effects manifest.
KidneySAFE IF PRESCRIBED
The use of Irnotop 40mg Injection in individuals with impaired kidney function is likely safe, with current evidence indicating that dose modification may be unnecessary. However, physician consultation is advised. This medication is contraindicated for patients undergoing dialysis.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Irnotop 40mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Irnotop 40mg Injection :
Should you forget a scheduled dose of Irnotop 40mg Injection, seek advice from your physician.
Facts to Know About Irnotop 40mg Injection
| Label | Value |
|---|---|
| Chemical Category | Camptothecin Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Behavior Class | Topoisomerase inhibitor |
